Presentations

Documents

Order by : Name | Date | Hits [ Ascendant ]

Metabolomics approaches to study NAFLD Metabolomics approaches to study NAFLD

Date added: 06/02/2018
Date modified: 06/02/2018
Filesize: 256 Bytes
Downloads: 79

Oral presentation given by ORU at the Federation of European Physiological Societies (FEPS) Congress, Vienna, Austria, 14th September 2017

NAFLD: Current & Future Therapeutic Approaches NAFLD: Current & Future Therapeutic Approaches

Date added: 06/02/2018
Date modified: 06/02/2018
Filesize: 256 Bytes
Downloads: 88

Oral presentation given by UNEW at the BASL School of Hepatology, Newcastle upon Tyne, UK, 28th June 2017

How common is NASH in your diabetes clinic? How common is NASH in your diabetes clinic?

hot!
Date added: 04/20/2018
Date modified: 04/20/2018
Filesize: 256 Bytes
Downloads: 116

Oral presentation given by UNITO at the 1st International Conference on Fatty Liver (ICFL), Seville, Spain, 1st - 3rd June 2017

NASH Therapeutics: Targets Under Evaluation in Early Phase Trials NASH Therapeutics: Targets Under Evaluation in Early Phase Trials

hot!
Date added: 04/20/2018
Date modified: 04/20/2018
Filesize: 256 Bytes
Downloads: 107

Oral presentation given by UNEW at the 1st International Conference on Fatty Liver (ICFL), Seville, Spain, 1st - 3rd June 2017

Why Should We Care About NAFLD? Why Should We Care About NAFLD?

hot!
Date added: 04/20/2018
Date modified: 04/20/2018
Filesize: 256 Bytes
Downloads: 116

Oral presentation given by UNEW at the 1st International Conference on Fatty Liver (ICFL), Seville, Spain, 1st - 3rd June 2017

The European NAFLD registry The European NAFLD registry

hot!
Date added: 04/20/2018
Date modified: 04/20/2018
Filesize: 256 Bytes
Downloads: 126

Oral presentation given by UNEW at the 1st International Conference on Fatty Liver (ICFL), Seville, Spain, 1st - 3rd June 2017

Adipose tissue expandability, Lipotoxicity and the Metabolic Syndrome Adipose tissue expandability, Lipotoxicity and the Metabolic Syndrome

Date added: 04/20/2018
Date modified: 04/20/2018
Filesize: 5.58 MB
Downloads: 57

Oral presentation given by UCAM at the 19th European Congress of Endocrinology (ECE), Satellite Symposium (Aegerion Pharmaceuticals), Lisbon, Portugal, 20th - 23rd May 2017

Hepatic lipotoxicity and mitochondrial dysfunction: impact of adipose tissue inflammation and... Hepatic lipotoxicity and mitochondrial dysfunction: impact of adipose tissue inflammation and...

hot!
Date added: 04/20/2018
Date modified: 04/20/2018
Filesize: 256 Bytes
Downloads: 101

"Hepatic lipotoxicity and mitochondrial dysfunction: impact of adipose tissue inflammation and insulin resistance"

Oral presentation given by CNR at the 51st European Society for Clinical Investigation (ESCI) conference, Genoa, Italy, 17th - 19th May 2017

Metabolic syndrome and NAFLD Metabolic syndrome and NAFLD

hot!
Date added: 04/20/2018
Date modified: 04/20/2018
Filesize: 256 Bytes
Downloads: 100

Oral presentation given by CNR at the Tuscan Hepatologists meeting, Italy, 10th - 11th May 2017

Serum phosphatidylglycerols (PG) are correlated with human obesity, gut dysbiosis, and are induced.. Serum phosphatidylglycerols (PG) are correlated with human obesity, gut dysbiosis, and are induced..

hot!
Date added: 04/20/2018
Date modified: 04/20/2018
Filesize: 256 Bytes
Downloads: 101

"Serum phosphatidylglycerols (PG) are correlated with human obesity, gut dysbiosis, and are induced by endotoxin"

Poster presentation given by ICAN at the Keystone Symposium “Gastrointestinal Control of Metabolism”, Copenhagen, Denmark, 9th - 13th May 2017